OncoAlert

OncoAlert

Download on the App Store

OncoAlert episodes

  • The OncoAlert Round Up Jan 5-11, 2024

    Discussing: 
     

    @ASCO @SocSurgOnc Germline Testing
    @ASTRO_org Partial Breast Irradiation in early Invasive Breast Cancer or DCIS
    ERMES in #ColorectalCancer
    Vision in #ProstateCancer
    AMPLIFY 201 #Cance #vaccine in CRC
    NACI study in #CervicalCancer
    FUTURE-SUPER trial in #TNBC
    Adj Abemaciclib+ET in HR+HER- HighRisk 

    5 min
  • The OncoAlert round Up September 15-21, 2023

    The @OncoAlert Newsletter  September 21, 2023
    Register at http://OncoAlert360.com

    Discussing:
    VP-2023 HRQoL in NATALEE #BreastCancer
    Oligomets in #ProstateCancer  treated w SBRT
    EV301:
    Enfortumab VendotinChemo in Urothelial Ca
    Targeting Innate immune pathways in Cancer #Immunotherapy
    Osimertinib early dose reduction as risk to brain mets in EGFR mutant #NSCLC #LungCancer

    4 min
  • The @oncoAlert Round Up September 1- 7, 2023

    The  @oncoAlert  Round Up
    September 1- 7, 2023
    REGISTER TO GET IT at  http://OncoAlert360.com 

    Discussing: 

    @fda Breakthrough therapy designations for Trastuzumab deruxtecan
    Sequencing Endocrine & Targeted Txin Hormone sensitive HER2- #breastcancer
    Neoadj palbociclib+giredestrant or anastrozole in ER+, HER2- early breast #cancer
    Exercise& Nutritionon Chemo Completion & pCR in Breast #Cancer
    Bladder-Sparing Treatment w/ Radical Dose RT Is Effective Alternative to Radical Cystectomy in Node+ Nonmets and more...

    3 min
  • The OncoAlert Round Up August 25-31, 2023

    Discussing:
    EMAapproval of Pembro+Trastuzumab+Chemo in Gastric Cancer based on KeyNote 811
    LUNARin metastatic #NSCLC
    ASTRRAin #BreastCancer
    Cannabinioidsin children with #Cancer
    IO in treatment of Localised GU Cancers
    LMWH synergistically enhances efficacy of adoptive and anti-PD-1-based #Immunotherapy 
    .....and more

    Register at www.oncoalert360.com

    3 min
  • The OncoAlert Round Up August 4-10, 2023

    REGISTERto get it www.OncoAlert360.com

    Discussing:

    @US_FDA approval of LONSURF+Bev in CRC
    selpercatinib in RET+ #NSCLC
    erdafitinib in Tumor Agnostic setting: RAGNAR
    Cause Specific Mortalityof Race & Ethnicity
    Stereotactic Body Reirradiationin Gyn Cancer
    Depression, anxiety & #Cancer Risk
    and more

    4 min

About OncoAlert

From the publisher's feed

The latest in Oncology News, happenings and research.